+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market: Focus on Product (Omega 3 & Omega 6 Product), Application, Country-Wise - Analysis and Forecast, 2021-2026

  • PDF Icon

    Report

  • 222 Pages
  • June 2022
  • Region: Asia Pacific
  • BIS Research
  • ID: 5610673
10% Free customization

Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market to Reach $1,984.1 Million by 2026

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) market was valued at $1.10 billion in 2020 and is projected to reach $1.98 billion in 2026, following a CAGR of 10.25% during the forecast period 2021-2026. The growth in the APAC PUFAs market is expected to be driven by increasing awareness regarding the health benefits of PUFAs, support from government organizations and institutions, and increasing chronic diseases.



Market Lifecycle Stage

The APAC PUFAs market is at the growing stage. There have been numerous research and development activities are underway to enhance PUFAs products and new innovative technologies in the PUFAs have been introduced in the market.

Furthermore, the PUFA market has been witnessing a shifting trend from animal-based to plant-based PUFA products. There are various types of animal and plant sources that provide PUFA. animal-based has the largest share in the PUFAs market, due to the increasing awareness regarding holistic lifestyle choices and environmental concerns plant-based is the fastest growing market in the Asia-Pacific region. As the consumer awareness towards global environmental concerns is driving the demand for sustainable ingredients and products across the globe is increasing. Consumers now show a preference for more eco-friendly products in various industries such as pharmaceutical, food and beverage, and others. This trend has coincided with a shift toward more holistic lifestyle choices, including the rising popularity of vegetarian, flexitarian, and vegan diets. This, in turn, is anticipated to increase the demand for the plant-based food source over the forecast period.

Impact

  • Chronic diseases and conditions are rising across the globe. An aging population and variations in societal behavior are leading to a steady increase in these common and long-term health problems. In addition to this, the population is growing, and with urbanization accelerating, people are adopting a more sedentary lifestyle. Such trends are pushing obesity rates and cases of diseases such as diabetes upward. To overcome such challenges, various public organizations and governments are promoting healthier lifestyles which include the benefits of omega-3 to fight against chronic diseases.
  • Various research has been conducted for a long time on the feasibility of innovative sources of PUFA which include plants, vegetables, animals, and others. Some of them include using microalgae as sources of omega-3 fatty acids. Diatoms are a prominent group of high omega-3-fatty acid-creating algae that play a crucial role in global climate change and ecosystem function. Such new innovative sources of PUFAs are anticipated to increase the demand for the market.

Impact of COVID-19

Impact of Covid-19 on PUFAs market was positive in comparison of other industries across the globe. during COVID-19, people's health awareness witnessed a sharp increase in the fight against the risk of various bacterial, viral, and other infections. Various chronic and severe infections lead to nutritional disorders and worsen affected people's nutritional status. Therefore, awareness toward diet and nutritional status during the COVID-19 pandemic witnessed a sharp increase. This, in turn, boosted the adoption of PUFAs.

Market Segmentation

by Application (Pharmaceutical, Dietary Supplements, Food and Beverages, Animal Feed, Others (Cosmetics, etc.))

The APAC PUFAs market in the Application segment is expected to be dominated by the dietary supplements. PUFAs are most commonly used in dietary supplements for the past few years, as offers various health benefits in the form of capsules and powders. The most important dietary of PUFAs are omega-3 and omega-6, as they are considered essential nutrients for humans.

by Product Type (Omega-3, Omega-6)

The APAC PUFAs market in product type segment is dominated by the omega-3 segment. This is due to benefits offered by Omega-3 to fight against diseases such as atherosclerosis, arthritis, hypertension, depression, myocardial infarction, thrombosis, and some cancers.

by Food Source (Plant Sources, Animal Sources)

The food source segment is dominated by animal source segment. Animal source PUFA play the most vital role in human health, ranging from conception across every stage of maturation, human development, and aging. For instance, fishes play a chief role in the brain and retina development throughout the fetal development process and the first two years of infant’s life.

by Forms (Ethyl Esters, Triglycerides, Others)

Ethyl ester forms of omega-3 fatty acid supplements are most widely consumed in the market mainly due to the cost, as ethyl esters are cheaper to produce than triglyceride forms of PUFA.

by Country

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Malaysia
  • Thailand
  • Australia and New Zealand
  • Rest of Asia-Pacific

China is expected to dominate the APAC PUFAs Market during the forecast period. It has been observed that in China, most of the industry such as food and beverages, pharmaceutical, cosmetics, among others are dependent on PUFAs, and witnessing positive growth over the forecast period. In addition to this, post-pandemic, in China, health awareness has risen to a new level. The country is witnessing change in lifestyles which is expanding the PUFAs market.

Recent Developments in APAC PUFAs Market

  • In November 2021, Aker BioMarine ASA partnered with Gambol Pet Food Group of China to expand its business in the Chinese pet food market, followed by more hirings in China.
  • In December 2020, VivoMega announced a partnership with Bioscope Viet Nam, aiming to target the Vietnamese market of omega-3 fatty acids.
  • In April 2020, Novosana B.V and LUS Health Ingredients partnered to work on the vegan omega-3 market.

Demand - Drivers and Limitations

Following are the demand drivers for the APAC PUFAs market:

  • Growing Awareness Regarding Health Benefits of Omega-3
  • Increasing Cases of Chronic Diseases
  • Support from Government Organization and Institutions

The market is expected to face some limitations too due to the following challenges:

  • Volatility in the Prices of PUFA Sources
  • Harmful Effects of High Ratio Consumption

How Can This Report Add Value to An Organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of PUFAs products such as product type, food source, forms available for deployment in applications. Moreover, the study provides the reader a detailed understanding of the different PUFAs based products by Application (pharmaceutical, dietary supplements, food and beverage, animal feeds and others).

Growth/Marketing Strategy: The APAC PUFAs market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been Partnerships, Collaborations, and Joint Ventures to strengthen their position in the APAC PUFAs. For instance, in December 2020, VivoMega announced a partnership with Bioscope Viet Nam, aiming to target the Vietnamese market of omega-3 fatty acids.

Competitive Strategy: Key players in the APAC PUFAs market analyzed and profiled in the study involve PUFAs-based product manufacturers that product type, forms, and food source products. Moreover, a detailed competitive benchmarking of the players operating in the APAC PUFAs market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, and analyzing company coverage, product portfolio, market penetration.

Some of the prominent names established in this market are:

  • Aker BioMarine ASA
  • BASF SE
  • CABIO Biotech (Wuhan) Co., Ltd.
  • Cargill, Incorporated.
  • Cellana, Inc.
  • Clover Corporation
  • Croda International PLC
  • DSM
  • Guangdong Runke Bioengineering Co. Ltd.
  • Huatai
  • Jindawei Group
  • KinOmega Biopharm Inc
  • Novasep
  • NovoSana B.V.
  • Omega Protein Corporation
  • Pelagia AS
  • Polaris
  • Sinomega Biotech Engineering Co., Ltd
  • Solutex
  • Stepan Company
  • Veramaris
  • VivoMega
Frequently Asked Questions about the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market

What is the estimated value of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market?

The Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market was estimated to be valued at $1218.1 Million in 2021.

What is the growth rate of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market?

The growth rate of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market is 10.3%, with an estimated value of $1984.1 Million by 2026.

What is the forecasted size of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market?

The Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market is estimated to be worth $1984.1 Million by 2026.

Who are the key companies in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market?

Key companies in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market include Aker BioMarine ASA, BASF SE, CABIO Biotech (Wuhan) Co., Ltd., Cargill, Incorporated., Cellana, Inc., Clover Corporation, Croda International PLC, DSM and Huatai.

Table of Contents

1 Markets
1.1 Industry Outlook
1.1.1 Market Definition
1.1.2 Supply Chain Analysis
1.1.3 Ecosystem/Ongoing Programs
1.1.3.1 Governments Initiatives
1.1.3.2 Consortiums and Associations
1.1.4 Patent Analysis
1.1.4.1 Patent Analysis (by Status)
1.1.4.2 Patent Analysis (by Inventor Type)
1.1.4.3 Patents Analysis (by Patent Office)
1.1.5 Supply Demand Analysis
1.1.6 Government Body Regulations in Asia-Pacific Region
1.2 Business Dynamics
1.2.1 Business Drivers
1.2.1.1 Growing Awareness Regarding Health Benefits of Omega-3
1.2.1.2 Increasing Cases of Chronic Diseases
1.2.1.3 Support from Government Organization and Institutions
1.2.2 Business Challenges
1.2.2.1 Volatility in the Prices of PUFA Sources
1.2.2.2 Harmful Effects of High Ratio Consumption
1.2.3 Business Strategies
1.2.3.1 Product Development
1.2.3.2 Market Development
1.2.4 Corporate Strategies
1.2.4.1 Mergers and Acquisitions
1.2.4.2 Partnerships, Collaborations, and Joint Ventures
1.2.4.3 Others
1.2.5 Business Opportunities
1.2.5.1 Increasing Aged Population
1.2.5.2 Search for Innovative Sources of PUFA
1.2.5.3 Growing Market for Supplements in Asia-Pacific Region
1.3 A Shift in the Trend from Animal-Based to Plant-Based PUFAs Products
1.4 Impact of COVID-19 on the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market

2 Application
2.1 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (By Application)
2.1.1 Pharmaceutical
2.1.2 Dietary Supplements
2.1.3 Food and Beverages
2.1.4 Animal Feed
2.1.5 Others (Cosmetics, etc.)
2.2 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application)

3 Products
3.1 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type)
3.1.1 Omega-3
3.1.1.1 Docosahexaenoic Fatty Acid (DHA)
3.1.1.2 Others (Eicosapentanoic Fatty Acid (EPA) and Alpha-Linolenic Fatty Acid (ALA))
3.1.2 Omega-6
3.1.2.1 Arachidonic Fatty Acid (ARA)
3.1.2.2 Others Linoleic Fatty Acid (LA) and Gamma-Linolenic Fatty Acid (GLA)
3.2 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type)
3.3 Food Source
3.3.1 Plant Sources
3.3.1.1 Microalgae
3.3.1.2 Others (Vegetables, Seeds)
3.3.2 Animal Sources
3.3.2.1 Fish
3.3.2.2 Shrimp
3.3.2.3 Others
3.4 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
3.5 Forms
3.5.1 Triglycerides
3.5.2 Ethyl Esters
3.5.3 Others (Re-Esterified Triglyceride (rTG))
3.6 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Forms)

4 Countries
4.1 China
4.1.1 Market
4.1.1.1 Buyer Attributes
4.1.1.2 Key Companies Operating in China
4.1.1.3 Business Challenges
4.1.1.4 Business Drivers
4.1.2 Application
4.1.2.1 China Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.1.3 Product
4.1.3.1 China Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.2 India
4.2.1 Market
4.2.1.1 Buyer Attributes
4.2.1.2 Key Companies Operating in India
4.2.1.3 Business Challenges
4.2.1.4 Business Drivers
4.2.2 Application
4.2.2.1 India Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.2.3 Product
4.2.3.1 India Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.3 Japan
4.3.1 Market
4.3.1.1 Buyer Attributes
4.3.1.2 Key Companies Operating in Japan
4.3.1.3 Business Challenges
4.3.1.4 Business Drivers
4.3.2 Application
4.3.2.1 Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.3.3 Product
4.3.3.1 Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.4 South Korea
4.4.1 Market
4.4.1.1 Buyer Attributes
4.4.1.2 Key Companies Operating in South Korea
4.4.1.3 Business Challenges
4.4.1.4 Business Drivers
4.4.2 Application
4.4.2.1 South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.4.3 Product
4.4.3.1 South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.5 Singapore
4.5.1 Market
4.5.1.1 Buyer Attributes
4.5.1.2 Key Companies Operating in Singapore
4.5.1.3 Business Challenges
4.5.1.4 Business Drivers
4.5.2 Application
4.5.2.1 Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.5.3 Product
4.5.3.1 Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.6 Malaysia
4.6.1 Market
4.6.1.1 Buyer Attributes
4.6.1.2 Key Companies Operating in Malaysia
4.6.1.3 Business Challenges
4.6.1.4 Business Drivers
4.6.2 Application
4.6.2.1 Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.6.3 Product
4.6.3.1 Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.7 Thailand
4.7.1 Market
4.7.1.1 Buyer Attributes
4.7.1.2 Key Companies Operating in Thailand
4.7.1.3 Business Challenges
4.7.1.4 Business Drivers
4.7.2 Application
4.7.2.1 Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.7.3 Product
4.7.3.1 Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.8 Australia and New Zealand
4.8.1 Market
4.8.1.1 Buyer Attributes
4.8.1.2 Key Companies Operating in Australia and New Zealand
4.8.1.3 Business Challenges
4.8.1.4 Business Drivers
4.8.2 Application
4.8.2.1 Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.8.3 Product
4.8.3.1 Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)
4.9 Rest-of-Asia-Pacific
4.9.1 Market
4.9.1.1 Buyer Attributes
4.9.1.2 Key Companies Operating in Rest-of-Asia-Pacific
4.9.1.3 Business Challenges
4.9.1.4 Business Drivers
4.9.2 Application
4.9.2.1 Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application)
4.9.3 Product
4.9.3.1 Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source)

5 Markets - Competitive Benchmarking & Company Profiles
5.1 Competitive Benchmarking
5.2 Market Share Analysis
5.3 Manufacturing Facility and Presence in Asia-Pacific
5.4 Company Profiles
5.4.1 Aker BioMarine ASA
5.4.1.1 Company Overview
5.4.1.2 Role of Aker BioMarine ASA in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.1.3 Product Portfolio
5.4.1.4 Business Strategies
5.4.1.4.1 Product Launch
5.4.1.5 Corporate Strategies
5.4.1.5.1 Mergers and Acquisitions
5.4.1.5.2 Partnerships, Collaborations, Joint Ventures, and Alliances
5.4.1.6 Strength and Weakness of Aker BioMarine ASA
5.4.2 BASF SE
5.4.2.1 Company Overview
5.4.2.2 Role of BASF SE in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.2.3 Product Portfolio
5.4.2.4 Corporate Strategies
5.4.2.4.1 Partnerships, Collaborations, Joint Ventures, and Alliances
5.4.2.5 Strength and Weakness of BASF SE
5.4.3 CABIO Biotech (Wuhan) Co., Ltd.
5.4.3.1 Company Overview
5.4.3.2 Role of CABIO Biotech (Wuhan) Co., Ltd in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.3.3 Product Portfolio
5.4.3.4 Business Strategies
5.4.3.4.1 Expansion
5.4.3.4.2 Product Launch
5.4.3.5 Strength and Weakness of CABIO Biotech (Wuhan) Co., Ltd
5.4.4 Cargill, Incorporated.
5.4.4.1 Company Overview
5.4.4.2 Role of Cargill, Incorporated. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.4.3 Product Portfolio
5.4.4.4 Business Strategies
5.4.4.4.1 Market Development
5.4.4.4.2 Product Developments
5.4.4.5 Strength and Weakness of Cargill, Incorporated.
5.4.5 Cellana, Inc.
5.4.5.1 Company Overview
5.4.5.2 Role of Cellana, Inc. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.5.3 Product Portfolio
5.4.5.4 Corporate Strategies
5.4.5.4.1 Partnerships, Joint Ventures, Collaborations, and Alliances
5.4.5.5 Strength and Weakness of Cellana, Inc.
5.4.6 Clover Corporation
5.4.6.1 Company Overview
5.4.6.2 Role of Clover Corporation in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.6.3 Product Portfolio
5.4.6.4 Business Strategies
5.4.6.4.1 Product Launch
5.4.6.5 Strength and Weakness of Clover Corporation
5.4.7 Croda International PLC
5.4.7.1 Company Overview
5.4.7.2 Role of Croda International PLC in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.7.3 Product Portfolio
5.4.7.4 Strength and Weakness of Croda International PLC
5.4.8 DSM
5.4.8.1 Company Overview
5.4.8.2 Role of DSM in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.8.3 Product Portfolio
5.4.8.4 Business Strategies
5.4.8.4.1 Product Launch
5.4.8.5 Corporate Strategies
5.4.8.5.1 Partnerships, Joint Ventures, Collaborations, and Alliances
5.4.8.5.2 Mergers and Acquisitions
5.4.8.6 Strength and Weakness of DSM
5.4.9 Guangdong Runke Bioengineering Co. Ltd.
5.4.9.1 Company Overview
5.4.9.2 Role of Guangdong Runke Bioengineering Co. Ltd. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.9.3 Product Portfolio
5.4.9.4 Strength and Weakness of Guangdong Runke Bioengineering Co. Ltd.
5.4.10 Huatai
5.4.10.1 Company Overview
5.4.10.2 Role of Huatai in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.10.3 Product Portfolio
5.4.10.4 Strength and Weakness of Huatai
5.4.11 Jindawei Group (Xiamen Kingdomway Group Company)
5.4.11.1 Company Overview
5.4.11.2 Role of Jindawei Group in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.11.3 Product Portfolio
5.4.11.4 Strength and Weakness of Jindawei Group
5.4.12 KinOmega Biopharm Inc
5.4.12.1 Company Overview
5.4.12.2 Role of KinOmega Biopharm Inc in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.12.3 Product Portfolio
5.4.12.4 Strength and Weakness of KinOmega Biopharm Inc
5.4.13 Novasep
5.4.13.1 Company Overview
5.4.13.2 Role of Novasep in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.13.3 Product Portfolio
5.4.13.4 Corporate Strategies
5.4.13.4.1 Mergers and Acquisitions
5.4.13.5 Strength and Weakness of Novasep
5.4.14 NovoSana B.V.
5.4.14.1 Company Overview
5.4.14.2 Role of NovoSana B.V. in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.14.3 Product Portfolio
5.4.14.4 Business Strategies
5.4.14.4.1 Market Developments
5.4.14.5 Corporate Strategies
5.4.14.5.1 Partnerships, Joint Ventures, Collaborations, and Alliances
5.4.14.6 Strength and Weakness of NovoSana B.V.
5.4.15 Omega Protein Corporation
5.4.15.1 Company Overview
5.4.15.2 Role of Omega Protein Corporation in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.15.3 Product Portfolio
5.4.15.4 Business Strategies
5.4.15.4.1 Market Developments
5.4.15.5 Strength and Weakness of Omega Protein Corporation
5.4.16 Pelagia AS
5.4.16.1 Company Overview
5.4.16.2 Role of Pelagia AS in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.16.3 Product Portfolio
5.4.16.4 Strength and Weakness of Pelagia AS
5.4.17 Pharma Marine AS
5.4.17.1 Company Overview
5.4.17.2 Role of Pharma Marine AS in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.17.3 Product Portfolio
5.4.17.4 Corporate Strategies
5.4.17.4.1 Partnerships, Collaborations, Joint Ventures, and Alliances
5.4.17.5 Strength and Weakness of Pharma Marine AS
5.4.18 Polaris
5.4.18.1 Company Overview
5.4.18.2 Role of Polaris in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.18.3 Product Portfolio
5.4.18.4 Business Strategies
5.4.18.4.1 Product Launch
5.4.18.5 Strength and Weakness of Polaris
5.4.19 Sinomega Biotech Engineering Co., Ltd
5.4.19.1 Company Overview
5.4.19.2 Role of Sinomega Biotech Engineering Co., Ltd in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.19.3 Product Portfolio
5.4.19.4 Business Strategies
5.4.19.4.1 Market Developments
5.4.19.5 Strength and Weakness of Sinomega Biotech Engineering Co., Ltd
5.4.20 Solutex
5.4.20.1 Company Overview
5.4.20.2 Role of Solutex in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.20.3 Product Portfolio
5.4.20.4 Business Strategies
5.4.20.4.1 Product Launch
5.4.20.5 Corporate Strategies
5.4.20.5.1 Partnership, Collaborations, Joint Ventures, and Alliances
5.4.20.6 Strength and Weakness of Solutex
5.4.21 Stepan Company
5.4.21.1 Company Overview
5.4.21.2 Role of Stepan Company in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.21.3 Product Portfolio
5.4.21.4 Corporate Strategies
5.4.21.4.1 Mergers and Acquisitions
5.4.21.5 Strength and Weakness of Stepan Company
5.4.22 Veramaris
5.4.22.1 Company Overview
5.4.22.2 Role of Veramaris in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.22.3 Product Portfolio
5.4.22.4 Corporate Strategies
5.4.22.4.1 Partnerships, Joint Ventures, Collaborations, and Alliances
5.4.22.5 Strength and Weakness of Veramaris
5.4.23 VivoMega
5.4.23.1 Company Overview
5.4.23.2 Role of VivoMega in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
5.4.23.3 Product Portfolio
5.4.23.4 Corporate Strategies
5.4.23.4.1 Partnerships, Collaborations, Joint Ventures, and Alliances
5.4.23.5 Strength and Weakness of VivoMega
5.5 Final Product Companies in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market

6 Research Methodology
List of Figures
Figure 1: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market, $Billion, 2020-2026
Figure 2: Market Dynamics of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Figure 3: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type), $Million, 2020-2026
Figure 4: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Figure 5: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Forms), $Million, 2020-2026
Figure 6: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Figure 7: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Country), $Million, 2020
Figure 8: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Coverage
Figure 9: Classification of Fatty Acid
Figure 10: Supply Chain Analysis of Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Figure 11: Polyunsaturated Fatty Acids Patent Trend, 2019-2021
Figure 12: Patent Analysis (by Status), 2019-2021
Figure 13: Patent Analysis (by Status), 2019-2021
Figure 14: Patent Analysis (by Inventor Type), 2019-2021
Figure 15: Patents Analysis (by Patent Office), 2019-2021
Figure 16: Distribution of Cancer Related Death, Global, 2020
Figure 17: Cardiovascular Diseases (CVDs) Deaths, Asia, 1990-2019
Figure 18: Average Annual Price of Fish Oil, Global, January 2015-June 2019
Figure 19: Share of Key Market Strategies and Developments, 2018-2021
Figure 20: Product Development and Innovation (by Company), 2018-2021
Figure 21: Market Development (by Company), 2018-2021
Figure 22: Mergers and Acquisitions (by Company), 2018-2021
Figure 23: Partnerships, Collaborations, and Joint Ventures (by Company), 2018-2021
Figure 24: Regional Population by Age Groups, Global, 2021
Figure 25: Share of Population Older than 65 Years, ASEAN Region, 2040
Figure 26: Market Size of Dietary Supplements, Global, 2018-2028
Figure 27: Market Value of Dietary Supplements, China, 2013-2020
Figure 28: Breakdown of Global Cosmetics Market, 2020
Figure 29: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Growth Matrix (by Country), $Million, 2020-2026
Figure 30: Animal Feed Production (Value and Growth Rate), China, 2015-2023
Figure 31: Animal Feed Production (Volume and Growth Rate), China, 2015-2023
Figure 32: Changes in Animal Feed Composition, in percentage (%), China, 2015-2023
Figure 33: Trends in Domestic Pharmaceutical Market, Size and Imports/Exports, Value, Japan, 2015-2019
Figure 34: Trends in Domestic Pharmaceutical Market Size and Imports/Exports, Value, South Korea, 2018-2020
Figure 35: Top Health Functional Foods Import Products, Value, South Korea, 2015-2019
Figure 36: Age Structure Between 2010 to 2020, Percentage (%), South Korea, 2010-2020
Figure 37: Sales Of Vitamins and Dietary Supplements Australia, Value, South Korea, 2018-2021
Figure 38: Competitive Benchmarking Matrix
Figure 39: Market Share Analysis of Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market, 2020
Figure 40: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market: Research Methodology
Figure 41: Top-Down and Bottom-Up Approach

List of Tables
Table 1: Key Consortiums and Associations in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 2: Supply Demand Analysis
Table 3: Recommendations for EPA and DHA Intake in Asia-Pacific Region
Table 4: Recommendations for ARA Intake in Asia-Pacific Region
Table 5: Products Pertaining to Pharmaceutical Industry in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 6: Products Pertaining to Dietary Supplements in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 7: Products Pertaining to Food and Beverages Industry in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 8: Products Pertaining to Animal Feed in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 9: Products Pertaining to Other Applications in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 10: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 11: Consumption of Docosahexaenoic Acid (DHA)
Table 12: Consumption of Eicosapentaenoic Fatty Acid (EPA)
Table 13: Consumption of Alpha-Linolenic Fatty Acid (ALA)
Table 14: Products Pertaining to Omega-3 in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 15: Strategies and Development Pertaining to Omega-3 in the Polyunsaturated Fatty Acids (PUFAs) Market
Table 16: Products Pertaining to Omega-6 in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 17: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Omega-3), $Million, 2020-2026
Table 18: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Omega-6), $Million, 2020-2026
Table 19: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type), $Million, 2020-2026
Table 20: Nutrition Information of Algae Oil Supplements
Table 21: Alpha-Linolenic Acid and Linoleic Acid Content
Table 22: Products Pertaining to Plant Source in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 23: Strategies and Development Pertaining to Plant Source in the Polyunsaturated Fatty Acids (PUFAs) Market
Table 24: Products Pertaining to Animal Source in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 25: Strategies and Development Pertaining to Animal Source in the Polyunsaturated Fatty Acids (PUFAs) Market
Table 26: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Plant Source), $Million, 2020-2026
Table 27: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Animal Source), $Million, 2020-2026
Table 28: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 29: Products Pertaining to Triglycerides (TGs) in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 30: Products Pertaining to Ethyl Esters in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 31: Products Pertaining to Other Forms in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market
Table 32: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Form), $Million, 2020-2026
Table 33: Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Country), $Million, 2020-2026
Table 34: Asia-Pacific Omega-3 Market (by Country), $Million, 2020-2026
Table 35: Asia-Pacific Omega-6 Market (by Country), $Million, 2020-2026
Table 36: China Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 37: China Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 38: India Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 39: India Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 40: Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 41: Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 42: South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 43: South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 44: Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 45: Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 46: Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 47: Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 48: Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 49: Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 50: Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 51: Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 52: Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026
Table 53: Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026
Table 54: Manufacturing Facility in Asia-Pacific
Table 55: Aker BioMarine ASA: Product Portfolio
Table 56: Aker BioMarine ASA: Product Launch
Table 57: Aker BioMarine ASA: Mergers and Acquisitions
Table 58: Aker BioMarine ASA: Partnerships, Collaborations, Joint Ventures, and Alliances
Table 59: BASF SE: Product Portfolio
Table 60: BASF SE: Partnerships, Collaborations, Joint Ventures, and Alliances
Table 61: CABIO Biotech (Wuhan) Co., Ltd: Product Portfolio
Table 62: CABIO Biotech (Wuhan) Co., Ltd: Expansion
Table 63: CABIO Biotech (Wuhan) Co., Ltd: Product Launch
Table 64: Cargill, Incorporated.: Product Portfolio
Table 65: Cargill, Incorporated.: Market Developments
Table 66: Cargill, Incorporated.: Product Developments
Table 67: Cellana, Inc.: Product Portfolio
Table 68: Cellana, Inc.: Partnerships, Joint Ventures, Collaborations, and Alliances
Table 69: Clover Corporation: Product Portfolio
Table 70: Clover Corporation: Product Launch
Table 71: Croda International PLC: Product Portfolio
Table 72: DSM: Product Portfolio
Table 73: DSM: Product Launch
Table 74: DSM: Partnerships, Joint Ventures, Collaborations and Alliances
Table 75: DSM: Mergers and Acquisitions
Table 76: Guangdong Runke Bioengineering Co. Ltd.: Product Portfolio
Table 77: Huatai: Product Portfolio
Table 78: Jindawei Group: Product Portfolio
Table 79: KinOmega Biopharm Inc: Product Portfolio
Table 80: Novasep: Product Portfolio
Table 81: Novasep: Mergers and Acquisitions
Table 82: NovoSana B.V.: Product Portfolio
Table 83: NovoSana B.V.: Market Developments
Table 84: NovoSana B.V.: Partnerships, Joint Ventures, Collaborations, and Alliances
Table 85: Omega Protein Corporation: Product Portfolio
Table 86: Omega Protein Corporation: Market Developments
Table 87: Pelagia AS: Product Portfolio
Table 88: Pharma Marine AS: Product Portfolio
Table 89: Pharma Marine AS: Partnerships, Collaborations, Joint Ventures, and Alliances
Table 90: Polaris: Product Portfolio
Table 91: Polaris: Product Launch
Table 92: Sinomega Biotech Engineering Co., Ltd: Product Portfolio
Table 93: Sinomega Biotech Engineering Co., Ltd: Market Developments
Table 94: Solutex: Product Portfolio
Table 95: Solutex: Product Launch
Table 96: Solutex: Partnership, Collaboration, Joint Ventures, and Alliances
Table 97: Stepan Company: Product Portfolio
Table 98: Stepan Company: Mergers and Acquisitions
Table 99: Veramaris: Product Portfolio
Table 100: Veramaris: Partnership, Joint Venture, Collaborations, and Alliances
Table 101: VivoMega: Product Portfolio
Table 102: VivoMega: Partnerships, Collaborations, Joint Ventures and Alliances
Table 103: Final Product Companies in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market

Samples

Loading
LOADING...

Companies Mentioned

  • Aker BioMarine ASA
  • BASF SE
  • CABIO Biotech (Wuhan) Co., Ltd.
  • Cargill, Incorporated.
  • Cellana, Inc.
  • Clover Corporation
  • Croda International PLC
  • DSM
  • Guangdong Runke Bioengineering Co. Ltd.
  • Huatai
  • Jindawei Group
  • KinOmega Biopharm Inc
  • Novasep
  • NovoSana B.V.
  • Omega Protein Corporation
  • Pelagia AS
  • Polaris
  • Sinomega Biotech Engineering Co., Ltd
  • Solutex
  • Stepan Company
  • Veramaris
  • VivoMega